Browse 17 Biopharma companies funded by National Institutes of Health. See funding amounts, founder contacts, and investment details.
custom aptamer development services
Evoq Therapeutics is a cancer immunotherapy company that provides disease-specific immune modulators.
Cerecor discovers, develops and commercializes neuroscience drugs.
Sur180 Therapeutics is a female-led business that focuses on novel ways to treating gynecological diseases.
GenNext Technologies is a platform that provides instrumentation, software, and services to structural biology researchers.
Intact Genomics provides high-quality life science products and large DNA fragment cloning related services
DIMERx operates as a biopharmaceutical company.
28bio is a neurotechnology company that develops brain-on-a-chip platform designed to capture neurological processes.
Co-Diagnostics is a molecular diagnostics company that enhances the output of molecular diagnostic tests.
Stem Pharm's synthetic biomaterials support the optimization of cell expansion.
Biotechnology company developing pharmaceutical therapies for nerve regeneration in the central nervous system.
Curi Bio integrates human stem cells, systems, and AI-enabled data analytics for the development of new therapeutics.
CaroGen develops vaccine candidates targeting hepatitis B and C, and other viral agents.
HDT Bio is a developer of RNA vaccines and therapeutics based on LION formulation technology.
Theraly is a preclinical-stage company whose mission is to develop innovative treatments for various forms of fibrotic disease.
CerSci Therapeutics is poised to deliver a new generation of non-opioid medicines to treat acute and chronic pain.
Prokaryotics is a biopharmaceutical company focused on the discovery and development of novel antibiotic classes.
View all companies funded by National Institutes of Health across every industry and funding stage.
View Full National Institutes of Health Portfolio